News

Neural engineers developing new brain implants for applications in brain-computer-interfaces, cortical stimulation, and neuroprosthetics have made continued progress at improving the function and the footprint of microelectrode arrays. Several research institutions and at least two commercial firms have literally added a new dimension to neural interfacing three-dimensional architecture of the cerebral cortex.

A newly published market research report from Neurotech Reports, the publisher of this newsletter, estimates that the worldwide market for neurotechnology products to be $9.1 billion in 2020, growing to $15.1 billion in 2024. This represents a CAGR of 13 percent. The report, titled The Market for Neurotechnology: 2020-2024, was authored Cavuoto, Jennifer French, Jeremy Koff, and Margot Puerta. It i…

Executives of several emerging bioelectronic medicine firms will present at the Third Annual Bioelectronic Medicine Forum, to take place on April 7, 2020 via Zoom video conference. The conference, produced , will also feature sessions related to investment, regulatory and reimbursement, and translational issues. Among the promising entrepreneurs tentatively scheduled to present are Ash Attia, CEO o…

It’s far too early to assess what effect the current coronavirus situation will have on the neurotechnology industry. But the timing is far from optimal. Just at the point when venture capital investment in neurotech startups had reached record levels, the current standstill in economic activity has created a time of uncertainty for entrepreneurs. The virus’ impact on VC investment will certainly be one of the topics to come up during our third annual Bioelectronic Medicine Forum on April 7.

The market for transcranial magnetic stimulation systems, which is currently driven largely -resistant depression, is likely to expand in the years ahead as manufacturers and investigators devise new therapeutic applications. TMS is currently approved major depression and obsessive compulsive disorder. Earlier this month, BrainsWay Ltd. announced results from a randomized controlled double-blind clinical trial assessing the safety and efficacy of the company’s deep TMS system for the treatment of adults with ADHD.

The 36th annual American Academy of Pain Medicine convened in National Harbor, MD in late February. The event is a culmination of the multiple disciplines in clinical practice, the latest research in a patient-centered approach, and emerging methods to treat people living with chronic pain. The overwhelming sentiment at the meeting was that treatments are not singular in nature but complementary an…

The 36th annual American Academy of Pain Medicine convened in National Harbor, MD in late February. The event is a culmination of the multiple disciplines in clinical practice, the latest research in a patient-centered approach, and emerging methods to treat people living with chronic pain. The overwhelming sentiment at the meeting was that treatments are not singular in nature but complementary an…

Executives of several emerging bioelectronic medicine firms will present at the Third Annual Bioelectronic Medicine Forum, to take place on April 7, 2020 in New York City. The conference, produced , will also feature sessions related to investment, regulatory and reimbursement, and translational issues. Among the promising entrepreneurs tentatively scheduled to present are Ash Attia, CEO of Bionic…

As is the case with most areas of science and engineering, the field of neurotechnology has moved forward as the result of pioneering discoveries that have led to new products, new therapeutic approaches, and new branches of investigation. As is also often the case, there can be disagreement among researchers as to who was the first to make that important discovery. Such was the case in the field of optics regarding who invented the laser.

New findings on the role of glial cells in modulating pain may have a fundamental impact on the market for spinal cord stimulation systems. The topic was one of the major themes at the recent NANS conference in Las Vegas and at least one vendor has invested heavily in the new approach. In a keynote address at the meeting, Linda Watkins from the University of Colorado described the role that non-neuronal cells such as glia play in the pain pathway.